About
The Department of Neurology provides clinical care of the highest quality, trains students, fellows, house-staff, and practicing physicians with the goal of creating leaders in neurology and neuroscience, and advances knowledge about neurological diseases via basic and clinical research programs using the most advanced methods to study the nervous system.
Titles
William S. and Lois Stiles Edgerly Professor of Neurology and Professor of Immunobiology
Chair, Neurology; Neurologist-in-Chief, Yale New Haven Hospital
Biography
Dr. Hafler is the William S. and Lois Stiles Edgerly Professor and Chairman Department of Neurology, Yale School of Medicine and is the Neurologist-in-Chief of the Yale-New Haven Hospital. He graduated magna cum laude in 1974 from Emory University with combined B.S. and M.Sc. degrees in biochemistry, and the University of Miami School of Medicine in 1978. He then completed his internship in internal medicine at Johns Hopkins followed by a neurology residency at Cornell Medical Center-New York Hospital in New York.
Dr. Hafler received training in immunology at the Rockefeller University then at Harvard where he joined the faculty in 1984. He was one of the Executive Directors of the Program in Immunology at Harvard Medical School and was on the faculty of the Harvard-MIT Health Science and Technology program where he was actively involved in the training of graduate students and post-doctoral fellows.
Hafler, in many respects, is credited with identifying the central mechanisms underlying the likely cause of MS. His early seminal work demonstrated that the disease began in the blood, not the brain, which eventually led to the development of Tysabri to treat the disease by blocking the movement of immune cells from the blood to the brain. He was the first to identify myelin-reactive T cells in the disease, published in Nature, showing that indeed, MS was an autoimmune disorder. He then went on to show why autoreactive T cells were dysregulated by the first identification of regulatory T cells in humans followed by demonstration of their dysfunctional state in MS. As a founding, Broad Institute associate member, Hafler identified the genes that cause MS, published in the New England Journal of Medicine and Nature. More recently, he identified the key transcription factors and signaling pathways associated with MS genes as potential treatment targets. Finally, he recently discovered that salt drives induction of these pathogenic myelin reactive T cells, both works published in Nature. Hafler was the Breakstone Professor of Neuroscience at Harvard, and became Chairman of Neurology at Yale in 2009, where he has built an outstanding clinical and research program that strongly integrates medical sciences. Hafler is among the most highly cited living neurologists and has received numerous honors including the Dystel Prize from the AAN for his MS research, the Raymond Adams Award from the ANA, and was the recipient of the NIH Javits Investigator Award, and The Dale McFarlin Prize by the International Society of Neuroimmunology. He is a member of AOA, the American Society of Clinical Investigation, and was elected into the National Academy of Medicine.
Appointments
Neurology
ChairDualNeurology
ProfessorPrimaryImmunobiology
ProfessorSecondary
Other Departments & Organizations
- Cancer Immunology
- Diabetes Research Center
- Hafler Lab
- Human and Translational Immunology Program
- Immunobiology
- Immunology
- Interdepartmental Neuroscience Program
- K12 Calabresi Immuno-Oncology Training Program (IOTP)
- Molecular Medicine, Pharmacology, and Physiology
- Multiple Sclerosis & Other Inflammatory Brain Disease
- Neural Disorders
- Neurology
- Neuroscience Track
- Pediatric Multiple Sclerosis Program
- Program for Neuroinflammation
- Program in Translational Biomedicine (PTB)
- Rheumatic Diseases Research Core
- Wu Tsai Institute
- Yale Cancer Center
- Yale Center for Immuno-Oncology
- Yale Combined Program in the Biological and Biomedical Sciences (BBS)
- Yale Medicine
- Yale Stem Cell Center
- Yale Ventures
Education & Training
- Post-Doctoral Fellowship
- Harvard Medical School (1986)
- Chief Resident
- The New York Hospital-Cornell Medical Center, and Memorial Sloan Kettering Cancer Institute (1982)
- Assistant Resident
- The New York Hospital-Cornell Medical Center, and Memorial Sloan Kettering Cancer Institute (1981)
- MD
- University of Miami School of Medicine (1978)
- BS
- Emory College, Chemistry (1974)
- MS
- Emory University (1974)
- Visiting Scientist
- Rockefeller University
Research
Overview
Hafler is a major force in bridging basic immunology, genetics, and neurology deeply probing mechanisms to understand MS. His seminal work in 1985 demonstrating systemic immune involvement in MS (NEJM, 1985) was followed by the first identification of myelin, autoreactive T cells in MS (Nature 1990). In 2004, Hafler was the first to identify human FoxP3 regulatory T cells and then demonstrated that they are defective in MS (JEM, Nature Med, 2011). In 2001, he co-led the international effort that identified the first MS genes outside of MHC (NEJM, 2007) now with over 100 identified genes (Nature 2011). In 2009 Hafler was recruited to become Chairman of Yale Neurology and Professor of Neurology and Immunobiology where he has rapidly built an outstanding clinical program that strongly integrates medical sciences. His scientific leadership has continued where he has deeply examined the function of MS associated risk haplotypes demonstrating their significant biologic effects (JCI 2014), identified NaCl as an environmental cause of of inflammation (Nature 2013), and epigentically fine-mapped MS causal variants discovering the molecular pathways causing MS (Nature 2014). He has received innumerable professional distinctions including being becoming a Jacob Javits Scholar of the NIH, ASCI membership, the ISI most highly cited list, the University of Miami Distinguished Alumni Award and the prestigious John Dystel Prize from the American Academy of Neurology and is a member of the National Academy of Medicine.
Medical Subject Headings (MeSH)
Academic Achievements and Community Involvement
Clinical Care
Are You a Patient?
Please visit the Yale Medicine website for information about the services we offer and making an appointment.
Related Yale Medicine Content
See All Related Content on Yale Medicine
Links & Media
News
- August 28, 2024Source: Yale News
Study Reveals Molecular Mechanism Behind MS and Other Autoimmune Diseases
- July 29, 2024Source: Yale Medicine
How to Manage Multiple Sclerosis (MS) Relapses
- July 10, 2024
Highlighting Yale’s Neuroscience Research
- May 10, 2024Source: Yale Medicine
How Immunotherapy Can Treat Cancer and Other Diseases: 8 Things to Know